About Michal Silverberg
Form D filings for ONL Therapeutics in 2024 list Michal Silverberg as director.
Michal Silverberg first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michal Silverberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michal Silverberg works with at each company, as listed on that company's latest Form D.
ONL Therapeutics, Inc. · Form D, Sep 16, 2024
DE
David Esposito
CEO & President, director
CC
Constance Chang
Executive officer
AF
Aaron Fletcher
Director
BB
Bill Burns
Director
DZ
David Zacks
Executive officer
MN
Marian Nakada
Director